Bauer J, Gold R, Adams O, Lassmann H (2015) Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS). Acta Neuropathol 130:751–764
Berger JR et al. (2013) PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80(15):1430–1438
Bolton CF, Rozdilsky B (1971) Primary progressive multifocal leukoencephalopathy. A case report. Neurology 21(1):72–77
Calabrese LH et al. (2007) Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum 56(7):2116–2128
Centers for Disease C. (1992) Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infection–United States. MMWR Morb Mortal Wkly Rep 41(30):541–545
Delgado-Alvarado M et al. (2013) Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia. J Neurol Sci 327(1–2):75–79
Fermaglich J, Hardman JM, Earle KM (1970) Spontaneous progressive multifocal leukoencephalopathy. Neurology 20(5):479–484
Gheuens S et al. (2010) Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81(3):247–254
Haider S et al. (2000) Progressive multifocal leukoencephalopathy and idiopathic CD4 + lymphocytopenia: a case report and review of reported cases. Clin Infect Dis 31(4):E20–E22
Hess R et al. (1994) PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus, and other JC virus tumor antigen cross-reactive antibodies of the PAb1601-1636 panel. Intervirology 37:47–52
Johansen KK et al. (2013) Progressive multifocal leukoencephalopathy in an immunocompetent patient? Case Rep Neurol 5(3):149–154
Koralnik IJ, Schellingerhout D, Frosch MP (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med 350(18):1882–1893
MacGregor RR (1986) Alcohol and immune defense. JAMA 256(11):1474–1479
Nieuwkamp DJ et al. (2015) PML in a patient without severe lymphocytopenia receiving dimethyl fumarate. N Engl J Med 372(15):1474–1476
Snyder MD, Storch GA, Clifford DB (2005) Atypical PML leading to a diagnosis of common variable immunodeficiency. Neurology 64(9):1661
Stoner GL, Ryschkewitsch CF, Walker DL, Soffer D, Webster HD (1988) A monoclonal antibody to SV40 large T-antigen labels a nuclear antigen in JC virus-transformed cells and in progressive multifocal leukoencephalopathy (PML) brain infected with JC virus. J Neuroimmunol 17:331–345
Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9(4):425–437
Vaklavas C et al. (2010) Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression. Virol J 7:256
Van der Kolk NM, Arts P, van Uden IWM, et al. (2016) Progressive multifocal leukoencephalopathy in an immunocompetent patient. Ann Clin Transl Neurol 3(3):226–232. doi:10.1002/acn3.279
Walker UA, Warnatz K (2006) Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18(4):389–395
Wollebo HS et al. (2015) Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol 77(4):560–570
Zonios DI et al. (2008) Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 112(2):287–294